Screening Activity Limitation and Safety Awareness Scale (SALSA): Difference between revisions
(Created page with "{{subst:Outcome Measures}}") |
mNo edit summary |
||
| Line 1: | Line 1: | ||
<div class="editorbox"> | <div class="editorbox"> | ||
'''Original Editor '''- | '''Original Editor '''- Redisha jakibanjar | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | ||
</div> | </div> | ||
== Objective< | == Objective<ref name=":0">SALSA Collaborative Study Group. SALSA scale (Screening Activity Limitation and Safety Awareness): users manual. Available from : file:///C:/Users/Redisha%20jakibanjar/Desktop/SALSA%20manual%20v1.1pdf_0.pdf </ref> == | ||
* Identify persons with activity limitation. | |||
* Assess the extent of Activity Limitation and the risk of increasing impairment. | |||
* Target people affected by leprosy, diabetes or other peripheral neuropathies | |||
* Be applicable world-wide. | |||
* Be used in combination with “Impairment” and “Participation-Restriction”4 tools in order to measure disablement from a holistic point of view. | |||
* Provide a means to measure the results of interventions whose goal is to improve function and/or self care. | |||
== Intended Population< | == Intended Population<ref name=":0" /> == | ||
People affected by | |||
* Leprosy | |||
* Diabetes and | |||
* Other peripheral neuropathies in both low-income and developed areas. | |||
== Method of Use == | == Method of Use == | ||
== Reference | == Reference == | ||
== Evidence == | == Evidence == | ||
| Line 20: | Line 30: | ||
=== Responsiveness === | === Responsiveness === | ||
=== Miscellaneous<span style="font-size: 20px; font-weight: normal;" class="Apple-style-span"></span> | === Miscellaneous<span style="font-size: 20px; font-weight: normal;" class="Apple-style-span"></span> === | ||
== Links == | == Links == | ||
Revision as of 16:36, 23 January 2019
Original Editor - Redisha jakibanjar
Top Contributors - Kim Jackson and Redisha Jakibanjar
Objective[1][edit | edit source]
- Identify persons with activity limitation.
- Assess the extent of Activity Limitation and the risk of increasing impairment.
- Target people affected by leprosy, diabetes or other peripheral neuropathies
- Be applicable world-wide.
- Be used in combination with “Impairment” and “Participation-Restriction”4 tools in order to measure disablement from a holistic point of view.
- Provide a means to measure the results of interventions whose goal is to improve function and/or self care.
Intended Population[1][edit | edit source]
People affected by
- Leprosy
- Diabetes and
- Other peripheral neuropathies in both low-income and developed areas.
